Greater than 80.0% as determined by SDS-PAGE.
LA/SS-B Human Recombinant produced in SF9 is a single, glycosylated, polypeptide chain having a calculated molecular mass of 48 kDa.
The LA/SS-B is expressed with a -6x His tag at N-terminus and purified by proprietary chromatographic techniques.
The LA/SS-B Human Recombinant is produced in Sf9 insect cells and is a single, glycosylated polypeptide chain with a calculated molecular mass of approximately 52 kDa . It is fused to a hexahistidine purification tag, which aids in its purification through proprietary chromatographic techniques . The biotinylated version of this protein is often used in various laboratory research applications .
In the nucleus, LA/SS-B facilitates the production of tRNAs by acting as an RNA polymerase III transcription factor. It binds to the U-rich 3’UTR of nascent transcripts, aiding in their folding and maturation . In the cytoplasm, it acts as a translation factor, facilitating the translation of specific mRNAs . As an RNA binding protein (RBP), LA/SS-B associates with subsets of mRNAs containing a 5’-terminal oligopyrimidine (5’TOP) motif, directing protein synthesis .
Anti-La/SS-B autoantibodies are frequently found in patients with Sjögren’s Syndrome, Systemic Lupus Erythematosus (SLE), and Subacute Cutaneous Lupus . These autoantibodies were originally identified as precipitating autoantibodies in the sera of Sjögren’s Syndrome patients . There is also a correlation between anti-La/SS-B and the absence of nephritis in SLE patients .